Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P Biotech ETF
XBI
|
+$284M |
| 2 |
Constellation Brands
STZ
|
+$284M |
| 3 |
Stellantis
STLA
|
+$268M |
| 4 |
VMW
VMware, Inc
VMW
|
+$263M |
| 5 |
NiSource
NI
|
+$234M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.82B |
| 2 |
Apple
AAPL
|
+$1.62B |
| 3 |
UnitedHealth
UNH
|
+$1.03B |
| 4 |
ExxonMobil
XOM
|
+$869M |
| 5 |
Tesla
TSLA
|
+$701M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.19% |
| 2 | Consumer Discretionary | 5.03% |
| 3 | Healthcare | 4.78% |
| 4 | Financials | 4.74% |
| 5 | Communication Services | 2.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2876
NRC Health Common Stock
NRC
$434M
| $753K | ﹤0.01% |
17,315
+7,739
| +81% | +$342K |
|
|
PINC
2877
DELISTED
Premier
PINC
| $753K | ﹤0.01% |
23,254
-32,659
| -58% | -$1.07M |
|
|
DMC
2878
Del Monte Corp
DMC
$1.4B
| $752K | ﹤0.01% |
24,964
-8,157
| -25% | -$237K |
|
2879
Standex International
SXI
$3.93B
| $749K | ﹤0.01% |
6,121
-11,236
| -65% | -$1.28M |
|
2880
Financial Institutions
FISI
$835M
| $749K | ﹤0.01% |
38,864
+9,675
| +33% | +$227K |
|
2881
Vital Farms
VITL
$520M
| $749K | ﹤0.01% |
48,952
+7,085
| +17% | +$112K |
|
|
ACH
2882
Accendra Health
ACH
$246M
| $749K | ﹤0.01% |
51,472
+1,005
| +2% | +$18K |
|
2883
PC Connection
CNXN
$2.21B
| $748K | ﹤0.01% |
16,640
+234
| +1% | +$10.7K |
|
2884
AnaptysBio
ANAB
$1.6B
| $748K | ﹤0.01% |
34,354
-5,997
| -15% | -$146K |
|
2885
Aurinia Pharmaceuticals
AUPH
$1.91B
| $745K | ﹤0.01% |
67,953
+3,230
| +5% | +$28.5K |
|
2886
Metropolitan Bank Holding Corp
MCB
$1.18B
| $744K | ﹤0.01% |
21,940
+7,170
| +49% | +$372K |
|
|
SILK
2887
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $744K | ﹤0.01% |
19,001
+8,819
| +87% | +$431K |
|
2888
National Healthcare
NHC
$3.41B
| $743K | ﹤0.01% |
12,801
+9,423
| +279% | +$542K |
|
2889
CALL
KB Home
KBH
$3.51B
| $743K | ﹤0.01% |
18,500
-127,800
| -87% | -$4.66M |
|
2890
Yext
YEXT
$568M
| $742K | ﹤0.01% |
77,204
-28,274
| -27% | -$218K |
|
|
TWO
2891
Two Harbors Investment
TWO
$1.27B
| $740K | ﹤0.01% |
50,299
+8,524
| +20% | +$139K |
|
|
SRCL
2892
DELISTED
Stericycle Inc
SRCL
| $739K | ﹤0.01% |
16,935
+4,518
| +36% | +$224K |
|
2893
Dime Commercial Bancshares
DCOM
$1.84B
| $738K | ﹤0.01% |
32,484
+12,957
| +66% | +$382K |
|
2894
Aehr Test Systems
AEHR
$3.55B
| $735K | ﹤0.01% |
23,695
-97,906
| -81% | -$3.15M |
|
|
PNT
2895
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
| $734K | ﹤0.01% |
100,958
-77,540
| -43% | -$575K |
|
2896
Par Pacific Holdings
PARR
$4.12B
| $731K | ﹤0.01% |
25,043
-146,876
| -85% | -$3.92M |
|
2897
Employers Holdings
EIG
$902M
| $731K | ﹤0.01% |
17,534
+4,386
| +33% | +$188K |
|
|
AMK
2898
DELISTED
AssetMark Financial Holdings, Inc.
AMK
| $727K | ﹤0.01% |
23,121
-5,802
| -20% | -$163K |
|
2899
St. Joe Company
JOE
$3.68B
| $727K | ﹤0.01% |
17,463
+930
| +6% | +$39.8K |
|
2900
GFL Environmental
GFL
$15.1B
| $725K | ﹤0.01% |
21,037
-11,758
| -36% | -$371K |
|
Similar funds
Barclays's Q1 2023 Portfolio in Review
As of Q1 2023, Barclays held 5,603 positions worth $218B, down 2.4% from $223B the previous quarter. Its ten largest holdings account for 47% of the portfolio.
Barclays withdrew a net $25.1B in Q1 2023, closing 541 positions and reducing 1,667 holdings. Its most notable exit was Coupa Software Incorporated, an estimated $128M position sold in full.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 12% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Barclays opened a new position in GE HealthCare worth $40.7M.
- Barclays's largest Q1 2023 buy was GE HealthCare: 496,712 shares worth $40.7M.
- Barclays added most to State Street SPDR S&P Biotech ETF in Q1 2023, an estimated $284M increase.
- Barclays's biggest Q1 2023 reduction was Microsoft, cutting an estimated $1.82B.
- Barclays fully exited Coupa Software Incorporated in Q1 2023, selling an estimated $128M.
- Barclays's ten largest holdings make up 47% of its $218B portfolio in Q1 2023.
- Barclays opened 345 new positions and closed 541 in Q1 2023.
- Barclays's portfolio value fell 2.4% quarter-over-quarter to $218B.
Based on Barclays's 13F filing for Q1 2023, filed 4 May 2023.